Skip to main content
SpringerLink
Log in

Role of community pharmacists in the prevention and management of the metabolic syndrome in Kuwait

  • Research Article
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Background The metabolic syndrome is a cluster of cardiovascular risk factors and its prevalence is alarmingly high in Kuwait, affecting nearly one third of the adult population. There is lack of information about the role of community pharmacists in the care of patients with the metabolic syndrome. Objective To assess the awareness and opinions of community pharmacists about the metabolic syndrome and identify the services they provide for identification, management and monitoring of patients with the metabolic syndrome. Setting Community pharmacies in Kuwait. Method A descriptive, cross-sectional study was performed on a randomly selected sample of 225 community pharmacists. Data were collected via face-to-face structured interview of the pharmacists using a pre-tested questionnaire. Main outcome measures Pharmacists’ knowledge and views on the metabolic syndrome, monitoring services provided, self-reported practices and perceived effectiveness of the various management interventions for the metabolic syndrome. Results The response rate was 97.8 %. Nine pharmacists claimed to know about the metabolic syndrome, but only one pharmacist could identify the condition correctly. After being given a definition of the metabolic syndrome, 67.7 % of respondents strongly agreed that its prevalence was rising in Kuwait. Nearly two thirds of respondents reported providing height and weight measurement service while 82.7 and 59.5 % of pharmacies provided blood pressure and blood glucose measurements, respectively. Waist circumference and lipid profile measurements were the least provided services (1.8 %). Respondents claimed to be involved in counseling patients on lifestyle modifications including increased exercise (98.1 %) and weight reduction through diet (96.9 %). Most pharmacists were involved in encouraging patients’ adherence with prescribed treatments (98.6 %) and perceived these as the most effective intervention for the management of the metabolic syndrome (95.0 %). Respondents were less involved in monitoring patients’ response to therapy (75.0 %) and documenting patient care services (5.0 %). Conclusion This study revealed significant deficits in awareness among community pharmacists about the metabolic syndrome. Given the proper education and training, community pharmacists could be important front-line contributors to the control of this emerging epidemic in Kuwait.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–5.

    Article  PubMed  CAS  Google Scholar 

  2. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24(4):683–9.

    Article  PubMed  CAS  Google Scholar 

  3. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56(14):1113–32.

    Article  PubMed  Google Scholar 

  4. Al Rashdan I, Al Nesef Y. Prevalence of overweight, obesity, and metabolic syndrome among adult Kuwaitis: results from community-based national survey. Angiology. 2010;61(1):42–8.

    Article  PubMed  CAS  Google Scholar 

  5. Al-Shaibani H, El-Batish M, Sorkhou I, Al-Shamali N, Al-Namash H, Habiba S, et al. Prevalence of insulin resistance syndrome in a primary health care center in Kuwait. Fam Med. 2004;36(8):540.

    PubMed  Google Scholar 

  6. Sorkhou EI, Al-Qallaf B, Al-Namash HA, Ben-Nakhi A, Al-Batish MM, Habiba SA. Prevalence of metabolic syndrome among hypertensive patients attending a primary care clinic in Kuwait. Med Princ Pract. 2004;13(1):39–42.

    Article  PubMed  CAS  Google Scholar 

  7. Moussa MA, Alsaeid M, Abdella N, Refai TM, Al-Sheikh N, Gomez JE. Prevalence of type 2 diabetes mellitus among Kuwaiti children and adolescents. Med Princ Pract. 2008;17(4):270–5.

    Article  PubMed  Google Scholar 

  8. Trinca CE. The pharmacist’s progress toward implementing pharmaceutical care. Am Pharm. 1995;Suppl:13–8.

    Google Scholar 

  9. Fornos JA, Andres NF, Andres JC, Guerra MM, Egea B. A pharmacotherapy follow-up program in patients with type-2 diabetes in community pharmacies in Spain. Pharm World Sci. 2006;28(2):65–72.

    Article  PubMed  Google Scholar 

  10. Krass I, Armour CL, Mitchell B, Brillant M, Dienaar R, Hughes J, et al. The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia. Diabet Med. 2007;24(6):677–83.

    Article  PubMed  CAS  Google Scholar 

  11. Bluml BM, McKenney JM, Cziraky MJ. Pharmaceutical care services and results in project ImPACT: hyperlipidemia. J Am Pharm Assoc (Wash). 2000;40(2):157–65.

    CAS  Google Scholar 

  12. Robinson JD, Segal R, Lopez LM, Doty RE. Impact of a pharmaceutical care intervention on blood pressure control in a chain pharmacy practice. Ann Pharmacother. 2010;44(1):88–96.

    Article  PubMed  Google Scholar 

  13. Lau R, Stewart K, McNamara KP, Jackson SL, Hughes JD, Peterson GM, et al. Evaluation of a community pharmacy-based intervention for improving patient adherence to antihypertensives: a randomised controlled trial. BMC Health Serv Res. 2010;10:34.

    Article  PubMed  Google Scholar 

  14. Olenak JL, Calpin M. Establishing a cardiovascular health and wellness program in a community pharmacy: screening for metabolic syndrome. J Am Pharm Assoc. 2010;50(1):32–6.

    Article  Google Scholar 

  15. Hammad EA, Yasein N, Tahaineh L, bsoul-Younes AM. A randomized controlled trial to assess pharmacist–physician collaborative practice in the management of metabolic syndrome in a university medical clinic in Jordan. J Manag Care Pharm. 2011;17(4):295–303.

    PubMed  Google Scholar 

  16. Matowe L, Al-Kandery AS, Bihzad SM. Pharmacy in Kuwait. Am J Health Syst Pharm. 2003;60(15):1591–2.

    PubMed  Google Scholar 

  17. Awad A, Abahussain E. Health promotion and education activities of community pharmacists in Kuwait. Pharm World Sci. 2010;32(2):146–53.

    Article  PubMed  Google Scholar 

  18. Lenth, RV. Java Applets for Power and Sample Size. (2006–2009) (cited Aug 24, 2012). Available from: http://www.stat.uiowa.edu/~rlenth/Power/.

  19. World Health Organization: how to investigate drug use in health facilities: Selected drug use indicators (WHO/DAP/93.1). 1993 (cited Aug 30, 2012). Available from: http://apps.who.int/medicinedocs/fr/d/Js2289e/.

  20. Snella KA, Canales AE, Irons BK, Sleeper-Irons RB, Villarreal MC, Levi-Derrick VE, et al. Pharmacy- and community-based screenings for diabetes and cardiovascular conditions in high-risk individuals. J Am Pharm Assoc. 2006;46(3):370–7.

    Article  Google Scholar 

  21. Schneiderhan ME, Batscha CL, Rosen C. Assessment of a point-of-care metabolic risk screening program in outpatients receiving antipsychotic agents. Pharmacotherapy. 2009;29(8):975–87.

    Article  PubMed  Google Scholar 

  22. Benavides S, Kohler LA, Souffrant G. A clinical pharmacist’s role in screening for metabolic syndrome in a rural pediatric ambulatory clinic. J Rural Health. 2011;27(2):184–9.

    Article  PubMed  Google Scholar 

  23. Lee K, Song YM, Sung J. Which obesity indicators are better predictors of metabolic risk?: healthy twin study. Obesity (Silver Spring). 2008;16(4):834–40.

    Article  Google Scholar 

  24. Kobayashi J, Murano S, Kawamura I, Nakamura F, Murase Y, Kawashiri MA, et al. The relationship of percent body fat by bioelectrical impedance analysis with blood pressure, and glucose and lipid parameters. J Atheroscler Thromb. 2006;13(5):221–6.

    Article  PubMed  CAS  Google Scholar 

  25. Malone M. Enhancing pharmacist involvement in weight management–time to get with the program. Ann Pharmacother. 2004;38(11):1961–3.

    Article  PubMed  Google Scholar 

  26. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.

    Article  PubMed  CAS  Google Scholar 

  27. Maguire TA, McElnay JC, Drummond A. A randomized controlled trial of a smoking cessation intervention based in community pharmacies. Addiction. 2001;96(2):325–31.

    Article  PubMed  CAS  Google Scholar 

  28. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25(6):1105–87.

    Article  PubMed  CAS  Google Scholar 

  29. Tsuyuki RT, Olson KL, Dubyk AM, Schindel TJ, Johnson JA. Effect of community pharmacist intervention on cholesterol levels in patients at high risk of cardiovascular events: the Second Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP-plus). Am J Med. 2004;116(2):130–3.

    Article  PubMed  Google Scholar 

  30. Ali F, Laurin MY, Lariviere C, Tremblay D, Cloutier D. The effect of pharmacist intervention and patient education on lipid-lowering medication compliance and plasma cholesterol levels. Can J Clin Pharmacol. 2003;10(3):101–6.

    PubMed  Google Scholar 

  31. McKenney JM, Bradberry JC, Talbert RL, Cahill E, Brown WV. National survey of pharmacists about coronary heart disease, hypercholesterolemia, nonprescription statintherapy, and pharmacists’ services. J Am Pharm Assoc. 2004;44(5):562–8.

    Article  Google Scholar 

  32. Dastani HB, Brown CM, O’Donnell DC. Combating the obesity epidemic: community pharmacists’ counseling on obesity management. Ann Pharmacother. 2004;38(11):1800–4.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We are grateful to the pharmacists who agreed to participate in this study. We thank Dr. Rashed Khazal for his assistance in reaching community pharmacies in Al-Jahra. Those who are interested in using the questionnaire are suggested to write to the corresponding author to obtain a copy.

Funding

None.

Conflicts of interest

Authors have no conflicts of interest with regard to the data produced.

Author information

Authors and Affiliations

  1. Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Kuwait University, P.O. Box 24923, 13110, Safat, Kuwait

    Maram G. Katoue & Samuel B. Kombian

  2. Department of Pharmacy Practice, Faculty of Pharmacy, Kuwait University, P.O. Box 24923, 13110, Safat, Kuwait

    Abdelmoneim I. Awad

Authors
  1. Maram G. Katoue
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Abdelmoneim I. Awad
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Samuel B. Kombian
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maram G. Katoue.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Katoue, M.G., Awad, A.I. & Kombian, S.B. Role of community pharmacists in the prevention and management of the metabolic syndrome in Kuwait. Int J Clin Pharm 35, 57–64 (2013). https://doi.org/10.1007/s11096-012-9705-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-012-9705-4

Keywords

Search

Navigation